Aurinia Pharmaceuticals Inc Share Price

Aurinia Pharmaceuticals Inc Share Price

NASDAQ: AUPH | Mid Cap
$15.41
-$0.07 (-0.45%) Last updated on 18 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Aurinia Pharmaceuticals Inc Stock Performance

Open
$15.32
Prev. Close
$15.48
Circuit Range
N/A
Day Range
$15.20 - $15.43
Year Range
$13.53 - $19.25
Volume
37,883
Average Traded
$15.35

Aurinia Pharmaceuticals Inc Share Price Today

As of 18 November 2026, Aurinia Pharmaceuticals Inc's share price is $15.41. The stock opened at $15.32, compared to its previous close of $15.48. During today's trading session, Aurinia Pharmaceuticals Inc's share price traded between $15.20 and $15.43, with an average price of $15.31. Over the past 52 weeks, the stock has recorded a high of $19.25 and a low of $13.53. In terms of performance, Aurinia Pharmaceuticals Inc's share price has risen by 0.55% over the last six months and is down 4.46% on a year-on-year basis.

Aurinia Pharmaceuticals Inc Share Price Chart

Line chart of the Aurinia Pharmaceuticals Inc price trend over the selected period. The price fell overall, ranging from 15.20 to 15.43, ending at 15.40.
$15.20$15.43
L
Show Current Price
H

Aurinia Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Market Cap
$2.07B
PE Ratio (TTM)
6.60
Dividend Yield
0.00%
EPS (TTM)
$2.35
Revenue (TTM)
$283.06B
Return On Equity (TTM)
47.80%
Profit Margin
101.46%
Debt to Equity
0.08
Quarterly Earnings Growth YoY
-84.96%

Aurinia Pharmaceuticals Inc Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$77.11$77.71$83.22$83.70
Net Profit$210.79$34.36$37.41$31.70
Net Profit Margin273.36%44.22%44.95%37.87%
Income ChangeN/A-83.70%8.88%-15.26%

Aurinia Pharmaceuticals Inc Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$134.03$175.51$235.13$283.06
Net Profit-$108.18-$78.02$5.75$287.20
Net Profit Margin-80.71%-44.45%2.45%101.46%
Income ChangeN/A27.88%107.37%4894.78%

About Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Aurinia Pharmaceuticals Inc Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$16.48
$15.39
-7.65%
Oct 2026
$16.12
$16.66
+2.71%
Sep 2026
$16.18
$16.23
-1.43%
Aug 2026
$14.76
$16.46
+10.77%
Jul 2026
$17.05
$14.86
-12.43%
Jun 2026
$15.38
$16.97
+10.73%
May 2026
$15.29
$15.32
-0.36%
Apr 2026
$15.16
$15.38
+3.64%
Mar 2026
$14.38
$14.84
+4.65%
Feb 2026
$14.63
$14.18
-2.48%
Jan 2026
$15.77
$14.54
-8.73%
Dec 2025
$16.09
$15.93
-1.23%

AUPH Share Price FAQs